New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A4640

Introduced
6/25/24  

Caption

Requires food manufacturers to disclose new food additives not reported to FDA.

Impact

The implementation of A4640 is poised to significantly affect state laws related to food safety and public health. By enhancing disclosure requirements, the bill aims to streamline information about food additives that may not have been adequately disclosed under federal laws. It encourages manufacturers to maintain transparency regarding the safety of new ingredients, thus fostering consumer trust. Additionally, the Commissioner of Health is empowered to enforce compliance through penalties for violations, creating a more accountable food manufacturing environment.

Summary

Assembly Bill A4640 requires food manufacturers in New Jersey to disclose new food additives that have not been reported to the FDA. This legislation mandates manufacturers to submit annual reports to the Department of Health detailing information on any food additive deemed 'generally recognized as safe' (GRAS) prior to its use in products for sale within the state. The motivation behind this requirement is to enhance public awareness and safety regarding food products, ensuring consumers have access to critical data about the substances used in their food and non-alcoholic beverages.

Contention

While the bill is largely supported for its potential to protect consumer interests and promote informed choices, it does face criticism, particularly from manufacturers concerned about the increased regulatory burden. Opponents argue that additional compliance requirements may stifle innovation or inadvertently create economic challenges for smaller manufacturers who might struggle to meet new reporting standards. The balance between safeguarding public health and ensuring a conducive business environment remains a central point of contention among stakeholders.

Companion Bills

No companion bills found.

Similar Bills

NJ S3135

Requires producers of plastic packaging and certain other plastic products to reduce quantity of plastic sold; restricts additional substances under "Toxic Packaging Reduction Act."

CT SB01130

An Act Implementing A Tax On Controlled Substances And Funding Regional Opioid Abuse Prevention And Treatment Programs.

CT SB00005

An Act Establishing A Surcharge On The Manufacture And Distribution Of Opioids And Funding For Opioid Abuse Prevention And Treatment.

CT SB00202

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Prescription Drug Control.

NJ A4367

Requires producers of plastic packaging and certain other plastic products to reduce quantity of plastic sold; restricts additional substances under "Toxic Packaging Reduction Act."

CT HB05235

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Cannabis Regulation.

NJ A4641

Prohibits several substances in sale, distribution, and manufacture of commercial foods.

CT SB00926

An Act Concerning The Presence Of Pfas In Certain Consumer Packaging.